As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Power Queen, the leader in lithium battery technology, introduces its latest innovation: the 12V 280Ah Low Temperature Deep ...

Explore several of the most common misconceptions about EV batteries and one of the most promising new technologies in the ...

Best solar battery storage in the UK to maximise your energy efficiency - Slap on the sunnies for this stunning selection of ...

As the Christmas bells draw near, Hinen Australia today announced the launch of its highly anticipated Christmas promotion, ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

This folder contains a read-only set all of the built-in policy definitions and initiatives (a.k.a policySetDefinitions) available in Azure's public cloud. They are organized into folders by category.

The US FDA has cleared the first-in-class tyrosine kinase 2 (Tyk2) inhibitor as Sotyktu, and BMS says it now plans to launch the new drug later this month, aiming to mount a challenge to Amgen's $ ...

The deal – which is worth up to $905 million with an upfront fee of $90 million – gives BMS full control of BridgeBio's experimental SHP2 inhibitor BBP-398, which is already in a phase 1 trial ...

November 2024 at the St. Regis Saadiyat Island Resort, Abu Dhabi, SIBEC 2024 is set to draw hundreds of fire and life safety ...